Gentian Diagnostics ASA — Director's Dealing 2022

Dec 15, 2022

Notification and public disclosure of transactions by Primary Insiders and their Close Associates

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Njaal Kind
2	Reason for the notification
a)	Position/status	CFO
b)	Initial notification/	Initial notification
	Amendment
3	Details of the issuer
a)	Name	Gentian Diagnostics ASA
b)	LEI	5967007LIEEXZXHNM861
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Share options. The exercise price for the options granted is NOK 46,67 being the average volume-weighted share price on the Oslo Stock Exchange from 1 January 2022 to 13 December 2022. The right to exercise the options is vested over a period of 2 years, with 50% of the options vesting by the end of each year as follows: (i) 50% of the options granted, no earlier than 3 years after the allocation date (ii) 50% of the options granted, no earlier than 4 years after the allocation date. The options are granted as part of the company's existing option program for key employees.
	Identification code	N/A
b)	Nature of the transaction	Allocation of options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		0	19,996
d)	Aggregated information
	- Aggregated volume	19,996
	- Price	0
e)	Date of the transaction	2022-12-15, 10:00 CET
f)	Place of the transaction	XOFF - Outside of trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Hilja Ibert
2	Reason for the notification
c)	Position/status	CEO
d)	Initial notification/	Initial notification
	Amendment
3	Details of the issuer
c)	Name	Gentian Diagnostics ASA
d)	LEI	5967007LIEEXZXHNM861
4	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Share options. The exercise price for the options granted is NOK 46,67 being the average volume-weighted share price on the Oslo Stock Exchange from 1 January 2022 to 13 December 2022. The right to exercise the options is vested over a period of 2 years, with 50% of the options vesting by the end of each year as follows: (i) 50% of the options granted, no earlier than 3 years after the allocation date (ii) 50% of the options granted, no earlier than 4 years after the allocation date. The options are granted as part of the company's existing option program for key employees.
	Identification code	N/A
b)	Nature of the transaction	Allocation of options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		0	80,000
d)	Aggregated information
	-	80,000
	Aggregated volume	0
	- Price
e)	Date of the transaction	2022-12-15, 10:00 CET
f)	Place of the transaction	XOFF - Outside of trading venue

1	associated	Details of the person discharging managerial responsibilities/person closely
a)	Name	Torsten Knüttel
2	Reason for the notification
a)	Position/status	Vice President R&D
b)	Initial notification/	Initial notification
	Amendment
3	Details of the issuer
a)	Name	Gentian Diagnostics ASA
b)	LEI	5967007LIEEXZXHNM861
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Share options. The exercise price for the options granted is NOK 46,67 being the average volume-weighted share price on the Oslo Stock Exchange from 1 January 2022 to 13 December 2022. The right to exercise the options is vested over a period of 2 years, with 50% of the options vesting by the end of each year as follows: (i) 50% of the options granted, no earlier than 3 years after the allocation date (ii) 50% of the options granted, no earlier than 4 years after the allocation date. The options are granted as part of the company's existing option program for key employees. N/A
	Identification code
b)	Nature of the transaction	Allocation of options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		0	10,000
d)	Aggregated information
	- Aggregated volume	10,000
	- Price	0
e)	Date of the transaction	2022-12-15, 10:00 CET
f)	Place of the transaction	XOFF - Outside of trading venue

Details of the person discharging managerial responsibilities/person closely associated
Name	Jack Andreassen
Reason for the notification
Position/status	Vice President Business Development
Initial notification/	Initial notification
Amendment
Details of the issuer
Name	Gentian Diagnostics ASA
LEI	5967007LIEEXZXHNM861
conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
Description of the financial instrument, type of instrument	Share options. The exercise price for the options granted is NOK 46,67 being the average volume-weighted share price on the Oslo Stock Exchange from 1 January 2022 to 13 December 2022. The right to exercise the options is vested over a period of 2 years, with 50% of the options vesting by the end of each year as follows: (i) 50% of the options granted, no earlier than 3 years after the allocation date (ii) 50% of the options granted, no earlier than 4 years after the allocation date. The options are granted as part of the company's existing option program for key employees.
Identification code	N/A
Nature of the transaction	Allocation of options
Price(s) and volume(s)
		Volume(s)
		10,000
- Aggregated volume
- Price	0
Date of the transaction	2022-12-15, 10:00 CET
Place of the transaction
	Aggregated information	Price(s) 0 10,000 XOFF - Outside of trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Markus Jaquemar
2	Reason for the notification
a)	Position/status	Vice President Sales and Marketing
b)	Initial notification/	Initial notification
	Amendment
3	Details of the issuer
a)	Name	Gentian Diagnostics ASA
b)	LEI	5967007LIEEXZXHNM861
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Share options. The exercise price for the options granted is NOK 46,67 being the average volume-weighted share price on the Oslo Stock Exchange from 1 January 2022 to 13 December 2022. The right to exercise the options is vested over a period of 2 years, with 50% of the options vesting by the end of each year as follows: (i) 50% of the options granted, no earlier than 3 years after the allocation date (ii) 50% of the options granted, no earlier than 4 years after the allocation date. The options are granted as part of the company's existing option program for key employees. N/A
b)	Nature of the transaction	Allocation of options
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		0	25,000
d)	Aggregated information -	25,000
	Aggregated volume	0
	- Price
e)	Date of the transaction	2022-12-15, 10:00 CET
f)	Place of the transaction	XOFF - Outside of trading venue